JOHN B KISIEL, M.D.
Osteopathic Medicine at 1 St, Rochester, MN

License number
Minnesota 47696
Category
Osteopathic Medicine
Type
Gastroenterology
License number
Minnesota 47696
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511

Professional information

John B Kisiel Photo 1

Dr. John B Kisiel, Rochester MN - MD (Doctor of Medicine)

Specialties:
Gastroenterology
Age:
52
Address:
Mayo Clinic Gastroenterology
200 1St St SW STE 9, Rochester 55905
(507) 284-2511 (Phone)
Languages:
English
Education:
Medical School
University of Illinois At Chicago / College of Medicine
Graduated: 2003


John Benjamin Kisiel Photo 2

John Benjamin Kisiel, Rochester MN

Specialties:
Internal Medicine, Gastroenterology
Work:
Rochester Methodist Hospital
201 W Center St, Rochester, MN 55902 Mayo Medical School
200 1St St Sw, Rochester, MN 55905 St Marys Hosp.
1216 2Nd St SW, Rochester, MN 55902
Education:
University of Illinois at Chicago (2004)


John Robert Kisiel Photo 3

John Robert Kisiel, Rochester MN

Specialties:
Internist
Address:
200 1St St Sw, Rochester, MN 55905
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Gastroenterology (Internal Medicine)


John Kisiel Photo 4

Methods And Materials For Noninvasive Detection Of Colorectal Neoplasia Associated With Inflammatory Bowel Disease

US Patent:
2013024, Sep 19, 2013
Filed:
Feb 22, 2013
Appl. No.:
13/773791
Inventors:
William R. Taylor - Lake City MN, US
Tracy C. Yab - Rochester MN, US
John B. Kisiel - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C12Q 1/68
US Classification:
435 611
Abstract:
The present invention provides methods and materials related to the detection of colorectal neoplasia (CRN) associated with inflammatory bowel disease (IBD). The present invention provides markers specific for colorectal neoplasia associated with inflammatory bowel disease in or associated with a subject's stool sample. In particular, the present invention provides methods and materials for identifying mammals (e.g., humans) having colorectal neoplasia associated with inflammatory bowel disease by detecting the presence and level of indicators of colorectal neoplasia such as, for example, epigenetic alterations (e.g., DNA methylation) (e.g., CpG methylation) (e.g., CpG methylation in coding or regulatory regions of BMP3, NDRG4, vimentin, EYA4) in DNA from a stool sample obtained from the mammal.